SCHEMBL23762804

SCHEMBL23762804

Cc1cn(C(C)(C)C)c(=O)n(C(C)(C)C)c1=O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23762803 0.86
SCHEMBL24616657 0.86
SCHEMBL23029099 0.81 BRD4 (0.35) ALDH1A1LMNAMAPT
SCHEMBL17586470 0.78 KMT2A (0.34)
SCHEMBL24616656 0.76 LMNA (0.33) ALDH1A1LMNA
SCHEMBL10234059 0.68 BRD4 (0.43) ALDH1A1LMNA
SCHEMBL12931774 0.66 RGS4 (0.32) ALDH1A1LMNA
SCHEMBL12149740 0.65 CA12 (0.32) ALDH1A1
SCHEMBL24952480 0.65 ALDH1A1 (0.35) ALDH1A1
SCHEMBL10129561 0.64 BRD4 (0.37) ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230173079-A1 Conjugate Molecules DIVERSE BIOTECH, INC. (US) 2023-06-08 US disclosed
US-20220402963-A1 NUCLEOTIDE PROBES Sony Group Corporation (JP) 2022-12-22 US disclosed
US-20220220314-A1 POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE Sony Group Corporation (JP) 2022-07-14 US disclosed
US-11352502-B2 Polymeric tandem dyes with linker groups Sony Group Corporation (JP) 2022-06-07 US disclosed
US-20210285953-A1 POLYMERIC DYES HAVING A BACKBONE COMPRISING ORGANOPHOSPHATE UNITS Sony Group Corporation (JP) 2021-09-16 US disclosed
US-20210253864-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS Sony Group Corporation (JP) 2021-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402963-A1 NUCLEOTIDE PROBES METTL3, SNRPA, L3MBTL3 ALDH1A1 1733/4885LMNA 43/4885MAPT 579/4885
US-11352502-B2 Polymeric tandem dyes with linker groups CHRM1, IK, TMT1A ALDH1A1 1531/4885LMNA 115/4885MAPT 11/4885
US-20220220314-A1 POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE H1-0, POLM, H1-2 ALDH1A1 1206/4885LMNA 34/4885MAPT 113/4885
US-20230173079-A1 Conjugate Molecules CNR2, CNR1, MAG ALDH1A1 2054/4885LMNA 3795/4885MAPT 1825/4885
US-20210253864-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS CHRM1, IK, TMT1A ALDH1A1 1531/4885LMNA 115/4885MAPT 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.